More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation therapy, according to researchers.
Cancer prevention methods include avoiding things that cause cancer, having a healthy lifestyle, getting screened, and using some medicines or surgery. Learn more about ways…
Researchers sought to assess whether nilotinib and dasatinib would have similar efficacy in patients with CML in chronic phase.
Preliminary findings from a phase II trial suggest that enasidenib offers clinically meaningful responses and a manageable safety profile in MDS.
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
No store does more than your H-E-B, where you’ll find savings on products you love, without compromise of convenience, quality or selection. Free Curbside!
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
The OncoAlert Newsletter is now out for June 23-29, 2023
This phase 2 nonrandomized clinical trial assesses the efficacy and safety of dual immune checkpoint inhibition in patients with aggressive thyroid carcinoma.
